Total Payments
$9,713
2024 Payments
$851.41
Companies
31
Transactions
239
Medicare Patients
3,020
Medicare Billing
$573,413
Payment Breakdown by Category
Food & Beverage$5,907 (60.8%)
Travel$3,806 (39.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,907 | 230 | 60.8% |
| Travel and Lodging | $3,806 | 9 | 39.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $4,050 | 56 | $0 (2020) |
| Nevro Corp. | $2,692 | 48 | $0 (2024) |
| Medtronic, Inc. | $1,172 | 36 | $0 (2024) |
| Abbott Laboratories | $442.52 | 29 | $0 (2023) |
| Vertos Medical, Inc. | $213.66 | 4 | $0 (2024) |
| ABBVIE INC. | $157.85 | 9 | $0 (2024) |
| Vertiflex, Inc. | $125.15 | 2 | $0 (2019) |
| Daiichi Sankyo Inc. | $102.41 | 8 | $0 (2018) |
| Allergan, Inc. | $78.56 | 5 | $0 (2022) |
| Amgen Inc. | $76.50 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $851.41 | 25 | Medtronic, Inc. ($648.43) |
| 2023 | $485.58 | 23 | Medtronic, Inc. ($277.13) |
| 2022 | $342.72 | 16 | Nevro Corp. ($131.93) |
| 2021 | $559.41 | 23 | Medtronic, Inc. ($221.76) |
| 2020 | $492.01 | 21 | Medtronic USA, Inc. ($236.17) |
| 2019 | $3,858 | 50 | Medtronic USA, Inc. ($3,600) |
| 2018 | $504.50 | 28 | Abbott Laboratories ($210.44) |
| 2017 | $2,620 | 53 | Nevro Corp. ($1,963) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Medtronic, Inc. | ACTIVOS 10 BONE CEMENT (Device) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/09/2024 | Medtronic, Inc. | ACTIVOS 10 BONE CEMENT (Device) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 09/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.14 | General |
| Category: Opioid Analgesic | ||||||
| 09/05/2024 | Medtronic, Inc. | ACTIVOS 10 BONE CEMENT (Device) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 08/27/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Orthopedic | ||||||
| 08/21/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $26.68 | General |
| 08/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/15/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/12/2024 | Medtronic, Inc. | ACTIVOS 10 BONE CEMENT (Device) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 06/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/10/2024 | Medtronic, Inc. | ACTIVOS 10 BONE CEMENT (Device) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 04/09/2024 | Medtronic, Inc. | ACTIVOS 10 BONE CEMENT (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 03/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/14/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: NEUROSCIENCE | ||||||
| 01/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $111.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $130.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/20/2024 | Medtronic, Inc. | ACTIVOS 10 BONE CEMENT (Device) | Food and Beverage | In-kind items and services | $42.81 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 01/20/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/19/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 01/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $141.84 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $46.04 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 834 | 7,853 | $571,338 | $158,917 |
| 2022 | 23 | 705 | 8,428 | $500,463 | $152,645 |
| 2021 | 20 | 651 | 6,674 | $454,166 | $139,195 |
| 2020 | 15 | 830 | 2,315 | $406,099 | $122,657 |
Total Patients
3,020
Total Services
25,270
Medicare Billing
$573,413
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 398 | $94,875 | $32,507 | 34.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 5,600 | $48,272 | $24,349 | 50.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 64 | 82 | $33,364 | $15,971 | 47.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 30 | 30 | $73,932 | $13,594 | 18.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 54 | 78 | $58,601 | $13,150 | 22.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 47 | 54 | $19,116 | $8,156 | 42.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 30 | 33 | $39,381 | $7,989 | 20.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 29 | 30 | $28,200 | $5,598 | 19.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 21 | 31 | $29,526 | $5,385 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $17,675 | $5,108 | 28.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 27 | 31 | $22,948 | $4,621 | 20.1% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 18 | 24 | $18,853 | $4,256 | 22.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 54 | 69 | $13,041 | $4,042 | 31.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 12 | 18 | $17,734 | $2,987 | 16.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 20 | 30 | $14,476 | $2,828 | 19.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 44 | $9,831 | $2,524 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 28 | $4,646 | $1,709 | 36.8% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 12 | 18 | $8,924 | $1,588 | 17.8% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 12 | 14 | $4,873 | $1,207 | 24.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 11 | 12 | $3,584 | $973.75 | 27.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 60 | 359 | $5,385 | $297.78 | 5.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 58 | 820 | $4,100 | $75.96 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 323 | $73,037 | $27,147 | 37.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 6,620 | $57,064 | $25,753 | 45.1% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 88 | 134 | $53,600 | $25,734 | 48.0% |
About Dr. Matthew Eagleson, D.O
Dr. Matthew Eagleson, D.O is a Pain Medicine healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1295020048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Eagleson, D.O has received a total of $9,713 in payments from pharmaceutical and medical device companies, with $851.41 received in 2024. These payments were reported across 239 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,907).
As a Medicare-enrolled provider, Eagleson has provided services to 3,020 Medicare beneficiaries, totaling 25,270 services with total Medicare billing of $573,413. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Saginaw, MI
- Active Since 06/09/2011
- Last Updated 07/06/2016
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1295020048
Products in Payments
- INTELLIS (Device) $4,005
- Senza Spinal Cord Stimulation System (Device) $2,244
- INTELLIS ADAPTIVESTIM (Device) $492.78
- ACTIVOS 10 BONE CEMENT (Device) $337.94
- Omnia (Device) $324.44
- Proclaim Family of SCS IPGs (Device) $234.50
- mild Device Kit (Device) $213.66
- BOTOX (Biological) $180.45
- RESTORE (Device) $158.12
- Superion ISS (Device) $125.15
- Senza (Device) $123.67
- DRG IPGs (Device) $96.00
- ACCURIAN (Device) $87.56
- AUTOFILL (Device) $79.60
- Aimovig (Biological) $76.50
- Morphabond ER (Drug) $66.48
- PROCLAIM (Device) $44.02
- UBRELVY (Drug) $40.53
- Nucynta (Drug) $39.34
- NURTEC ODT (Drug) $38.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.